Tungaraza Tongeji E, Ahmed Wakil, Chira Chinonyelum, Turner Erin, Mayaki Susan, Nandhra Harpal Singh, Edwards Tom, Farooq Saeed
Consultant General Adult Psychiatrist (Rehabilitation), Partnerships in Care Ltd., Beverley House, 527-529 City Road, Birmingham, B617 8LL (Formerly Consultant EIS, Wolverhampton), UK.
Consultant General Adult Psychiatrist, MHHTT, Park House, North Manchester, Manchester Mental Health & Social Care Trust, UK.
Ther Adv Psychopharmacol. 2017 Mar;7(3):103-111. doi: 10.1177/2045125316683151. Epub 2016 Dec 1.
To describe the pattern of antipsychotic drug prescribing in patients with first episode psychosis, with more emphasis in the use of clozapine in this group of patients.
A cross-sectional survey involving six early intervention service (EIS) teams in the West Midlands was conducted. Data was extracted from case notes and electronic records by clinicians working in each participating team. The pattern of antipsychotic prescribing and the changes that took place after being accepted in EIS, including the use of clozapine, was established. Clinicians involved in the treatment of patients in each team rated the overall clinical response to treatment based on the presence or absence of positive psychotic symptoms.
431 patients with FEP were included in the final analysis. Low antipsychotic discontinuation rate was observed, with the majority (88.2%) still being prescribed antipsychotics. Most (77.3%) were prescribed second-generation antipsychotic drugs, with olanzapine (21.8%) and aripiprazole (19.7%) being the most frequently prescribed antipsychotics. There was low rate use of antipsychotic combinations (7.4%), high dose antipsychotic regime (3.9%), low depot antipsychotic prescribing (9.3%), and clozapine use was low (9.7%). On average, three antipsychotics were tried before clozapine was initiated and it took on average 19.5 months from being accepted into EIS to clozapine being initiated.
The majority of patients were prescribed antipsychotics within the guidelines. EIS was associated with an overall low antipsychotic discontinuation. There was also a short waiting time before clozapine was initiated following patients being accepted into EIS.
描述首发精神病患者抗精神病药物的处方模式,重点关注该组患者中氯氮平的使用情况。
对西米德兰兹郡的六个早期干预服务(EIS)团队进行了横断面调查。各参与团队的临床医生从病例记录和电子记录中提取数据。确定了抗精神病药物的处方模式以及被EIS接收后发生的变化,包括氯氮平的使用情况。每个团队参与患者治疗的临床医生根据是否存在阳性精神病症状对治疗的总体临床反应进行评分。
431例首发精神病患者纳入最终分析。观察到抗精神病药物停药率较低,大多数(88.2%)仍在服用抗精神病药物。大多数(77.3%)患者使用第二代抗精神病药物,其中奥氮平(21.8%)和阿立哌唑(19.7%)是最常用的抗精神病药物。抗精神病药物联合使用的比例较低(7.4%),高剂量抗精神病药物治疗方案的比例较低(3.9%),长效抗精神病药物的处方比例较低(9.3%),氯氮平的使用率较低(9.7%)。在开始使用氯氮平之前,平均尝试了三种抗精神病药物,从被EIS接收至开始使用氯氮平平均用时19.5个月。
大多数患者按照指南使用抗精神病药物。EIS与总体较低的抗精神病药物停药率相关。患者被EIS接收后,开始使用氯氮平的等待时间也较短。